官方服务：
资源简介：
Drug dosage and study groups.
应用场景：
创建时间：
2022-12-30
相关数据集
Sugammadex ED90 dose to reverse the rocuronium neuromuscular blockade in obese patients
ABSTRACT Objective: to determine the ED90 (minimum effective dose in 90% of patients) of sugammadex for the reversal of rocuronium-induced moderate neuromuscular blockade (NMB) in patients with grade
DataCite Commons2022-06-02 更新110
Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer
The primary objective is to determine the dose of aflibercept to be further studied in combination with irinotecan/5-fluorouracil/isovorin (FOLFIRI) in Japanese patients with metastatic colorectal can
NIAID Data Ecosystem90
Treatment groups and sample sizes.
#64 mg/kg not included in experiment 1 block A therefore only 5 mice. *Only used in experiment 1 block A. PI = post infection.
NIAID Data Ecosystem70
Supplementary tables: Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer
These are peer-reviewed supplementary materials for the article 'Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer' published in the Journal of
Mendeley Data2024-06-25 更新90
Supplementary materials: Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer
These are peer-reviewed supplementary materials for the article 'Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer' published in the Journal of
becaris.figshare.com2024-04-12 更新80
